CPHI vs LIN · rev $4.5M vs P/E 34, rev $33.99B
China Pharma Holdings Inc (CPHI) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
CPHI currently screens at market cap $29.0M. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the CPHI and LIN stock pages for the full models.
Not investment advice.